title: Gastroprotection with proton-pump inhibitors in high-risk cardiovascular patients: who to target and for how long?
authors.affiliation: a Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School , Boston , MA , USA.
authors.forename: Muthiah
authors.initials: M
authors.lastname: Vaduganathan
authors.affiliation: a Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School , Boston , MA , USA.|b Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA) , Odense University Hospital , Odense , Denmark.
authors.forename: Manan
authors.initials: M
authors.lastname: Pareek
authors.affiliation: a Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School , Boston , MA , USA.
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications*; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D054328:Proton Pump Inhibitors
keywords: Cardiovascular safety; coronary artery disease; gastrointestinal bleeding; proton-pump inhibitors